SONN icon

Sonnet BioTherapeutics

20 hedge funds and large institutions have $532K invested in Sonnet BioTherapeutics in 2016 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

Holders
20
Holders Change
+5
Holders Change %
+33.33%
% of All Funds
0.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
1
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
TDC
1
Thompson Davis & Co
Virginia
$135K 312,824 -74,373 -19%
Vanguard Group
2
Vanguard Group
Pennsylvania
$94K 217,873
IC
3
Intersect Capital
California
$53K 123,783
BIT
4
BlackRock Institutional Trust
California
$44K 101,212
Geode Capital Management
5
Geode Capital Management
Massachusetts
$39K 92,136
GHAM
6
Gilman Hill Asset Management
Connecticut
$26K 59,890
Stifel Financial
7
Stifel Financial
Missouri
$25K 57,999 +57,999 New
CDH
8
Charles D. Hyman
$19K 44,444
Bank of America
9
Bank of America
North Carolina
$18K 42,875 -209,953 -83%
EVC
10
Eidelman Virant Capital
Missouri
$16K 37,900 -39,100 -51%
Citadel Advisors
11
Citadel Advisors
Florida
$15K 34,851 +34,851 New
SI
12
SII Investments
Wisconsin
$13K 30,000
CL
13
CSS LLC
Illinois
$10K 22,728
VKH
14
Virtu KCG Holdings
New York
$9K 21,065 +21,065 New
Northern Trust
15
Northern Trust
Illinois
$8K 17,646
First Manhattan
16
First Manhattan
New York
$3K 8,500 +8,500 New
BFA
17
BlackRock Fund Advisors
California
$2K 5,776 +448 +8%
Barclays
18
Barclays
United Kingdom
$2K 3,600 +3,600 New
IA
19
IFP Advisors
Florida
$1K 2,000 +2,000 New
BIM
20
BlackRock Investment Management
Delaware
-3,485 Closed
Morgan Stanley
21
Morgan Stanley
New York
-1,464 Closed
Wells Fargo
22
Wells Fargo
California
$0 500 +500 New